|
1
|
Cooper DS and Biondi B: Subclinical
thyroid disease. Lancet. 379:1142–1154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tagami T, Tamanaha T, Shimazu S, Honda K,
Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A and Naruse M:
Lipid profiles in the untreated patients with Hashimoto thyroiditis
and the effects of thyroxine treatment on subclinical
hypothyroidism with Hashimoto thyroiditis. Endocr J. 57:253–258.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Biondi B and Cooper DS: The clinical
significance of subclinical thyroid dysfunction. Endocr Rev.
29:76–131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klein I and Ojamaa K: Thyroid hormone and
the cardiovascular system. N Engl J Med. 344:501–509. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isles CG and Paterson JR: Identifying
patients at risk for coronary heart disease: implications from
trials of lipid-lowering drug therapy. QJM. 93:567–574. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
LaRosa JC, He J and Vupputuri S: Effect of
statins on risk of coronary disease: a meta-analysis of randomized
controlled trials. JAMA. 282:2340–2346. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walsh JP, Bremner AP, Bulsara MK, O'leary
P, Leedman PJ, Feddema P and Michelangeli V: Thyroid dysfunction
and serum lipids: A community-based study. Clin Endocrinol (Oxf).
63:670–675. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kvetny J, Heldgaard PE, Bladbjerg EM and
Gram J: Subclinical hypothyroidism is associated with a low-grade
inflammation, increased triglyceride levels and predicts
cardiovascular disease in males below 50 years. Clin Endocrinol
(Oxf). 61:232–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iqbal A, Jorde R and Figenschau Y: Serum
lipid levels in relation to serum thyroid-stimulating hormone and
the effect of thyroxine treatment on serum lipid levels in subjects
with subclinical hypothyroidism: The Tromsø Study. J Intern Med.
260:53–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cooper DS, Halpern R, Wood LC, Levin AA
and Ridgway EC: L-Thyroxine therapy in subclinical hypothyroidism.
A double-blind, placebo-controlled trial. Ann Intern Med.
101:18–24. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nyström E, Caidahl K, Fager G, Wikkelsö C,
Lundberg PA and Lindstedt G: A double-blind cross-over 12-month
study of L-thyroxine treatment of women with ‘subclinical’
hypothyroidism. Clin Endocrinol (Oxf). 29:63–75. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jaeschke R, Guyatt G, Gerstein H,
Patterson C, Molloy W, Cook D, Harper S, Griffith L and Carbotte R:
Does treatment with L-thyroxine influence health status in
middle-aged and older adults with subclinical hypothyroidism? J Gen
Intern Med. 11:744–749. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meier C, Staub JJ, Roth CB, Guglielmetti
M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R and Müller B:
TSH-controlled L-thyroxine therapy reduces cholesterol levels and
clinical symptoms in subclinical hypothyroidism: a double blind,
placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol
Metab. 86:4860–4866. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong WM, Sheikh MH, Lumb PJ, Naoumova RP,
Freedman DB, Crook M, Doré CJ and Finer N: A 6-month randomized
trial of thyroxine treatment in women with mild subclinical
hypothyroidism. Am J Med. 112:348–354. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Razvi S, Ingoe L, Keeka G, Oates C,
McMillan C and Weaver JU: The beneficial effect of L-thyroxine on
cardiovascular risk factors, endothelial function, and quality of
life in subclinical hypothyroidism: randomized, crossover trial. J
Clin Endocrinol Metab. 92:1715–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Monzani F, Caraccio N, Kozàkowà M, Dardano
A, Vittone F, Virdis A, Taddei S, Palombo C and Ferrannini E:
Effect of levothyroxine replacement on lipid profile and
intima-media thickness in subclinical hypothyroidism: A
double-blind, placebo-controlled study. J Clin Endocrinol Metab.
89:2099–2106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caraccio N, Ferrannini E and Monzani F:
Lipoprotein profile in subclinical hypothyroidism: Response to
levothyroxine replacement, a randomized placebo-controlled study. J
Clin Endocrinol Metab. 87:1533–1538. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Higgins JP, Altman DG, Gøtzsche PC, Jüni
P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L and Sterne JA:
Cochrane Bias Methods Group; Cochrane Statistical Methods Group;
Cochrane Statistical Methods Group: The Cochrane Collaboration's
tool for assessing risk of bias in randomised trials. BMJ.
343:d59282011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hopp L: Risk of bias reporting in Cochrane
systematic reviews. Int J Nurs Pract. 21:683–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Higgins JP and Green S: Cochrane Handbook
for Systematic Reviews of Interventions: Cochrane Book Series. The
Cochrane Collaboration and John Wiley & Sons Ltd.; West Sussex:
2008, View Article : Google Scholar
|
|
21
|
Song X, Meng Z, Jia Q, Zhang L, Xu K, Tan
J, Zhang G, Zheng W, Li X and Zhang J: Different radioiodine dose
for remnant thyroid ablation in patients with differentiated
thyroid cancer: a meta-analysis. Clin Nucl Med. 40:774–779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anagnostis P, Efstathiadou ZA, Slavakis A,
Selalmatzidou D, Poulasouchidou M, Katergari S, Karathanasi E,
Dogramatzi F and Kita M: The effect of L-thyroxine substitution on
lipid profile, glucose homeostasis, inflammation and coagulation in
patients with subclinical hypothyroidism. Int J Clin Pract.
68:857–863. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Danese MD, Ladenson PW, Meinert CL and
Powe NR: Clinical review 115: effect of thyroxine therapy on serum
lipoproteins in patients with mild thyroid failure: a quantitative
review of the literature. J Clin Endocrinol Metab. 85:2993–3001.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jorde R, Waterloo K, Storhaug H, Nyrnes A,
Sundsfjord J and Jenssen TG: Neuropsychological function and
symptoms in subjects with subclinical hypothyroidism and the effect
of thyroxine treatment. J Clin Endocrinol Metab. 91:145–153. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Biondi B, Lombardi G and Palmieri EA:
Screening and treatment for subclinical thyroid disease. JAMA.
291:15622004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biondi B and Klein I: Hypothyroidism as a
risk factor for cardiovascular disease. Endocrine. 24:1–13. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanis BC, Westendorp GJ and Smelt HM:
Effect of thyroid substitution on hypercholesterolaemia in patients
with subclinical hypothyroidism: a reanalysis of intervention
studies. Clin Endocrinol (Oxf). 44:643–649. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Çatlı G, Anık A, Tuhan H Ünver, Böber E
and Abacı A: The effect of L-thyroxine treatment on hypothyroid
symptom scores and lipid profile in children with subclinical
hypothyroidism. J Clin Res Pediatr Endocrinol. 6:238–244. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Villar HC, Saconato H, Valente O and
Atallah AN: Thyroid hormone replacement for subclinical
hypothyroidism. Cochrane Database Syst Rev. CD0034192007.PubMed/NCBI
|
|
30
|
Caraccio N, Natali A, Sironi A, Baldi S,
Frascerra S, Dardano A, Monzani F and Ferrannini E: Muscle
metabolism and exercise tolerance in subclinical hypothyroidism: a
controlled trial of levothyroxine. J Clin Endocrinol Metab.
90:4057–4062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Monzani F, Di Bello V, Caraccio N, Bertini
A, Giorgi D, Giusti C and Ferrannini E: Effect of levothyroxine on
cardiac function and structure in subclinical hypothyroidism: a
double blind, placebo-controlled study. J Clin Endocrinol Metab.
86:1110–1115. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ross DS: Bone density is not reduced
during the short-term administration of levothyroxine to
postmenopausal women with subclinical hypothyroidism: a randomized,
prospective study. Am J Med. 95:385–388. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yazici M, Gorgulu S, Sertbas Y, Erbilen E,
Albayrak S, Yildiz O and Uyan C: Effects of thyroxin therapy on
cardiac function in patients with subclinical hypothyroidism: index
of myocardial performance in the evaluation of left ventricular
function. Int J Cardiol. 95:135–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
